Most Profitable Pharmaceutical Products Companies
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Income
| Net Income | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | PLRZ | Polyrizon Ltd Ordinary | (0.24) | 8.60 | (2.07) | ||
| 2 | NWBO | Northwest Biotherapeutics | (0.06) | 3.60 | (0.20) | ||
| 3 | TLX | Telix Pharmaceuticals Limited | 0.05 | 3.26 | 0.16 | ||
| 4 | MNKD | MannKind Corp | (0.22) | 1.87 | (0.41) | ||
| 5 | DVAX | Dynavax Technologies | 0.08 | 1.50 | 0.12 | ||
| 6 | MEIP | MEI Pharma | (0.03) | 1.92 | (0.05) | ||
| 7 | XOMAP | XOMA Corp | 0.05 | 0.58 | 0.03 | ||
| 8 | XOMAO | XOMA Corporation | 0.08 | 0.27 | 0.02 | ||
| 9 | VCEL | Vericel Corp Ord | (0.13) | 2.57 | (0.32) | ||
| 10 | NAGE | Niagen Bioscience, | 0.08 | 7.38 | 0.57 | ||
| 11 | DTIL | Precision BioSciences | 0.05 | 6.40 | 0.35 | ||
| 12 | MTEX | Mannatech Incorporated | (0.16) | 4.25 | (0.66) | ||
| 13 | MCRB | Seres Therapeutics | (0.02) | 5.21 | (0.10) | ||
| 14 | CEROW | CERo Therapeutics Holdings | 0.13 | 20.93 | 2.74 | ||
| 15 | MIRA | MIRA Pharmaceuticals, Common | 0.01 | 5.96 | 0.05 | ||
| 16 | TVGNW | Tevogen Bio Holdings | 0.01 | 8.44 | 0.12 | ||
| 17 | ASBPW | Aspire Biopharma Holdings, | 0.07 | 12.51 | 0.88 | ||
| 18 | ASBP | Aspire BioPharma, | (0.29) | 12.38 | (3.64) | ||
| 19 | KLTOW | Klotho Neurosciences, | 0.02 | 18.74 | 0.40 | ||
| 20 | EXOZ | eXoZymes, | (0.09) | 6.26 | (0.58) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.